Details of issuance or disposal
Monthly exercise status of the 17th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions)
Number of shares delivered during the month: 830,000 new shares (no treasury shares transferred)
Exercise ratio subject to the exercise restrictions: 10% (①/②) against 8,300,000 listed shares as of the payment date for the issuance
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 17th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 830,000 new shares (no treasury shares transferred) |
| Dilution Rate | Exercise ratio subject to the exercise restrictions: 10% (①/②) against 8,300,000 listed shares as of the payment date for the issuance |
| Total number of issued shares | 8,300,000 shares → Not disclosed |
| Exercise price | 26 March 2026: ¥394. Details of the adjustment provisions are not disclosed in this document. |
| Number of Stock Acquisition Rights | Total issued: 18,100 rights; exercised during the month: 8,300 rights; unexercised at issuance: 18,100 rights; unexercised at month-end: 9,800 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 16 March 2026 / Type Issuance of the 17th Series of Stock Acquisition Rights (with exercise price adjustment provisions) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of these stock acquisition rights in March 2026.